UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 16, 2005
DRAGON PHARMACEUTICAL INC.
-------------------------
(Exact name of registrant as specified in its charter)
Florida 0-27937 65-0142474
------- ------- ----------
(State or Other Jurisdiction of (Commission File Number) (IRS Employer
Incorporation) Identification No.)
1055 Hastings Street, Suite 1900
Vancouver, British Columbia V6E 2E9
---------------------------- -------
(Address of Principal Executive Offices) (Zip Code)
(604) 669-8817
--------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Section 2 - Financial Information
Item 2.02 Results of Operations and Financial Condition
Dragon Pharmaceutical Inc. announced its financial results for the first
quarter of 2005 on the attached press release.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
Exhibit No. Exhibit Description
---------- -------------------
99 Press release announcing financial results for the
first quarter of 2005.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DRAGON PHARMACEUTICAL INC.,
a Florida Corporation
Dated: May 18, 2005 /s/ Maggie Deng
--------------------------------------
Maggie Deng
Chief Operating Officer
3
EXHIBIT INDEX
Exhibit No. Description
---------- -----------
99 Press release dated May 16, 2005 titled "Dragon
Pharmaceutical Announces Financial Results for the
First Quarter of 2005 with 65% Increase in Revenues
from the prior year"
4